| Literature DB >> 24321617 |
Seung-Nam Kim1, Ah-Reum Doo2, Ji-Yeun Park2, Hyunwoo J Choo3, Insop Shim2, Jongbae J Park4, Younbyoung Chae1, Bena Lee5, Hyejung Lee1, Hi-Joon Park6.
Abstract
This study first showed the behavioural benefits of novel combination therapy of L-dopa with acupuncture on Parkinson's disease, and its underlying mechanisms within basal ganglia. The previous study reported that acupuncture may improve the motor function of a Parkinson's disease (PD) mouse model by increasing the dopamine efflux and turnover ratio of dopamine. Hence, we hypothesised that combining L-dopa with acupuncture would have a behavioural benefit for those with PD. We performed unilateral injections of 6-OHDA into the striatum of C57Bl/6 mice to model hemi-Parkinsonian attributes. To test motor function and dyskinetic anomalies, we examined cylinder behaviour and abnormal involuntary movement (AIM), respectively. We found that (1) a 50% reduced dose of L-dopa (7.5 mg/kg) combined with acupuncture showed an improvement in motor function that was comparable to mice given the standard dose of L-dopa treatment (15 mg/kg) only, and that (2) the combination treatment (L-dopa +acupuncture) was significantly superior in reducing AIM scores when equivalent doses of L-dopa were used. The combination treatment also significantly reduces the abnormal increase of GABA contents in the substantia nigra compared to the standard L-dopa treatment. Furthermore, abnormal expression of FosB, the immediate early gene of L-dopa induced dyskinesia (LID), was mitigated in the striatum by the combination treatment. All of these results indicate that acupuncture enhances the benefits of L-dopa on motor function with reduced dose of L-dopa and alleviating LID by normalising neurochemical imbalance within the basal ganglia.Entities:
Keywords: Acupuncture; FosB; GABA; Levodopa-induced dyskinesia; Parkinson's disease; l-dopa combination treatment
Mesh:
Substances:
Year: 2013 PMID: 24321617 PMCID: PMC4180515 DOI: 10.1016/j.brainres.2013.11.028
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252